Literature DB >> 25637260

Risk factors for West Nile virus infection and disease in populations and individuals.

Ruth R Montgomery1, Kristy O Murray.   

Abstract

West Nile virus (WNV) is a mosquito-borne enveloped positive-strand RNA virus that emerged in North America in 1999 in New York City. Over the past 15 years, WNV has become established throughout the USA and has spread into Canada, Mexico and the Caribbean. CDC reports indicate >41,000 clinical cases, including more than 1700 fatalities. An estimated 3 million people in the USA may have been infected to date. Infection with WNV is dependent on many factors including climate, mosquito habitats and immunologically naïve bird populations. In addition, variations within individuals contribute to the risk of severe disease, in particular, advanced age, hypertension, immunosuppression and critical elements of the immune response. Recent advances in technology now allow detailed analysis of complex immune interactions relevant to disease susceptibility.

Entities:  

Keywords:  West Nile virus; aging; avian reservoir; epizootic spread; immune response; mosquito vector; mouse model

Mesh:

Substances:

Year:  2015        PMID: 25637260      PMCID: PMC4939899          DOI: 10.1586/14787210.2015.1007043

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  120 in total

1.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

2.  CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis.

Authors:  K L Tyler; J Pape; R J Goody; M Corkill; B K Kleinschmidt-DeMasters
Journal:  Neurology       Date:  2005-12-28       Impact factor: 9.910

3.  TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Authors:  Stacey L Demento; Nathalie Bonafé; Weiguo Cui; Susan M Kaech; Michael J Caplan; Erol Fikrig; Michel Ledizet; Tarek M Fahmy
Journal:  J Immunol       Date:  2010-07-26       Impact factor: 5.422

4.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly.

Authors:  Kok-Fai Kong; Karine Delroux; Xiaomei Wang; Feng Qian; Alvaro Arjona; Stephen E Malawista; Erol Fikrig; Ruth R Montgomery
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

6.  Virus and antibody dynamics in acute west nile virus infection.

Authors:  Michael P Busch; Steven H Kleinman; Leslie H Tobler; Hany T Kamel; Philip J Norris; Irina Walsh; Jose L Matud; Harry E Prince; Robert S Lanciotti; David J Wright; Jeffrey M Linnen; Sally Caglioti
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

7.  A paradoxical role for neutrophils in the pathogenesis of West Nile virus.

Authors:  Fengwei Bai; Kok-Fai Kong; Jianfeng Dai; Feng Qian; Lin Zhang; Charles R Brown; Erol Fikrig; Ruth R Montgomery
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

8.  Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I.

Authors:  Penghua Wang; Alvaro Arjona; Yue Zhang; Hameeda Sultana; Jianfeng Dai; Long Yang; Philippe M LeBlanc; Karine Doiron; Maya Saleh; Erol Fikrig
Journal:  Nat Immunol       Date:  2010-09-05       Impact factor: 25.606

9.  Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013.

Authors:  Sridhar V Basavaraju; Matthew J Kuehnert; Sherif R Zaki; James J Sejvar
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

10.  Experimental infection of North American birds with the New York 1999 strain of West Nile virus.

Authors:  Nicholas Komar; Stanley Langevin; Steven Hinten; Nicole Nemeth; Eric Edwards; Danielle Hettler; Brent Davis; Richard Bowen; Michel Bunning
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more
  16 in total

Review 1.  The continued threat of emerging flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

2.  Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.

Authors:  Konstantinos Tsioris; Namita T Gupta; Adebola O Ogunniyi; Ross M Zimnisky; Feng Qian; Yi Yao; Xiaomei Wang; Joel N H Stern; Raj Chari; Adrian W Briggs; Christopher R Clouser; Francois Vigneault; George M Church; Melissa N Garcia; Kristy O Murray; Ruth R Montgomery; Steven H Kleinstein; J Christopher Love
Journal:  Integr Biol (Camb)       Date:  2015-10-20       Impact factor: 2.192

Review 3.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 4.  Role of Immune Aging in Susceptibility to West Nile Virus.

Authors:  Yi Yao; Ruth R Montgomery
Journal:  Methods Mol Biol       Date:  2016

Review 5.  Age-related alterations in immune responses to West Nile virus infection.

Authors:  R R Montgomery
Journal:  Clin Exp Immunol       Date:  2016-10-17       Impact factor: 4.330

6.  Virus infection of the CNS disrupts the immune-neural-synaptic axis via induction of pleiotropic gene regulation of host responses.

Authors:  Olga A Maximova; Daniel E Sturdevant; John C Kash; Kishore Kanakabandi; Yongli Xiao; Mahnaz Minai; Ian N Moore; Jeff Taubenberger; Craig Martens; Jeffrey I Cohen; Alexander G Pletnev
Journal:  Elife       Date:  2021-02-18       Impact factor: 8.140

Review 7.  Reduced dynamic range of antiviral innate immune responses in aging.

Authors:  Ryan D Molony; Anna Malawista; Ruth R Montgomery
Journal:  Exp Gerontol       Date:  2017-08-16       Impact factor: 4.032

8.  Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis.

Authors:  Megan E Cahill; Samantha Conley; Andrew T DeWan; Ruth R Montgomery
Journal:  BMC Infect Dis       Date:  2018-06-22       Impact factor: 3.090

9.  Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study.

Authors:  Andrea Visentin; Vincenzo Nasillo; Monia Marchetti; Isacco Ferrarini; Rossella Paolini; Rosaria Sancetta; Gian Matteo Rigolin; Francesca Cibien; Marcello Riva; Chiara Briani; Serena Marinello; Francesco Piazza; Filippo Gherlinzoni; Mauro Krampera; Renato Bassan; Antonio Cuneo; Mario Luppi; Gianpietro Semenzato; Roberto Marasca; Livio Trentin
Journal:  Hemasphere       Date:  2020-06-08

10.  Predictors, Neuroimaging Characteristics and Long-Term Outcome of Severe European Tick-Borne Encephalitis: A Prospective Cohort Study.

Authors:  Thorsten Lenhard; Daniela Ott; Nurith J Jakob; Mirko Pham; Philipp Bäumer; Francisco Martinez-Torres; Uta Meyding-Lamadé
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.